lymphoma cell…

Overview of attention for article published in Investigational New Drugs, July 2006

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)

Mentioned by

patent: 12 patents

Citations

dimensions_citation: 44 Dimensions

Readers on

mendeley: 23 Mendeley
connotea: 1 Connotea

Summary Patents Dimensions citations

So far, Altmetric has seen 12 patents that reference this research output.

Combination therapies using HDAC inhibitors

Grant US-10799469-B2

United States of America

13 Oct 2020

Combination therapies using HDAC inhibitors

Grant US-10285959-B2

United States of America

14 May 2019

Pharmaceutical formulations of HDAC inhibitors

Grant US-9957227-B2

United States of America

01 May 2018

Pharmaceutical formulations of HDAC inhibitors

Grant US-9856211-B2

United States of America

02 Jan 2018

FREQUENCY MODULATED DRUG DELIVERY (FMDD)

Grant EP-2373171-B1

European Patent Office

01 Nov 2017

Histone deacetylase (HDAC) inhibitors for the treatment of cancer

Grant US-9603926-B2

United States of America

28 Mar 2017

Therapy for MLL-rearranged leukemia

Grant US-8859502-B2

United States of America

14 Oct 2014

Pharmaceutical formulations of HDAC inhibitors

Grant US-8835501-B2

United States of America

16 Sep 2014

Histone deacetylase (HDAC) inhibitors (PXD101) for the treatment of cancer alone or in…

Grant US-8828392-B2

United States of America

09 Sep 2014

Methods of synthesis of certain hydroxamic acid compounds

Grant US-8642809-B2

United States of America

04 Feb 2014

THERAPY FOR MLL-REARRANGED LEUKEMIA

Application WO-2012037008-A3

World Intellectual Property Organisation (WIPO)

22 Nov 2012

FREQUENCY MODULATED DRUG DELIVERY (FMDD)

Application EP-2373171-A1

European Patent Office

12 Oct 2011